Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3LP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,365
Award facts
- Contract value 100% obligated
- $27,365.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,365.25 delivery order to AmerSourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 15, 2026, for the supply of Gardasil 9 Syringe 0.5ML, a human papillomavirus vaccine. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerSourceBergen Drug Corp operates as a critical vendor in the federal pharmaceutical supply chain, supporting military treatment facilities and other government healthcare systems with a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive federal contract awards with DLA demonstrate its capability to meet competitive procurement requirements across multiple therapeutic domains. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerSourceBergen has consistently fulfilled federal medical supply needs through firm fixed-price delivery orders ranging from minimal to substantial values, reinforcing its status as a key provider within the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FG3LP?
SPE2DR26FG3LP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FG3LP worth?
The government has obligated $27,365 on SPE2DR26FG3LP.
Is contract SPE2DR26FG3LP an order under another contract?
Yes. SPE2DR26FG3LP is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3LP competed?
The extent of competition for SPE2DR26FG3LP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award